- Bruton's tyrosine kinase inhibitors and their current status in the treatment of chronic lymphocytic leukemia2023 | First Faculty of Medicine
- Long-term Treatment of Patients with X-linked Hypogammablobulinaemia (Bruton ´s disease) - 3 Case Studies2003 | First Faculty of Medicine
- X-linked Hypogammaglobulinaemia (Bruton´s Disease) - Three Case Studies and Molecular Genetic Studies in Their Families2004 | First Faculty of Medicine
- X-linked Hypogammaglobulinaemia (Bruton´s Disease) - Three Case Studies and Molecular Genetic Studies in Their Families2004 | Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Long-term Treatment of Patients with X-linked Hypogammablobulinaemia (Bruton ´s disease) - 3 Case Studies2003 | Faculty of Medicine in Hradec Králové
- Brutonova agamaglobulinemie - kazuistika2006 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia2008 | Second Faculty of Medicine
- Bruton's Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib Counteract Anthracycline Resistance in Cancer Cells Expressing AKR1C32020 | Faculty of Pharmacy in Hradec Králové
- Research Report University Hospital for clinical evaluation of PCI-32765MCL3002Publication without faculty affiliation
- Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Cytokiny v supernatantech lymfocytárních kultur pacientů trpících X vázanou hypogamaglobulinemií (morbus Bruton)Publication without faculty affiliation
- Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux2022 | Faculty of Pharmacy in Hradec Králové
- Targeting phosphatidylinositol 3 kinase-beta and -delta for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma2020 | First Faculty of Medicine
- Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia2022 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Report of University Hospital Hradec Králové to the clinical trial protocol No: PCYC-1115-CAPublication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. PCYC-1130-CAPublication without faculty affiliation
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Contiguous x-chromosome deletion syndrome encompassing the BTK, TIMM8A, TAF7L, and DRP2 genes2007 | Second Faculty of Medicine
- Use of ibrutinib as "bridging" for allogeneic hematopoietic stem cell transplantation from haploidentic donor and subsequent therapy of residual disease after transplantation in a patient with highly adverse mantle cell lymphoma2019 | First Faculty of Medicine
- Fixed duration therapy in patients with chronic lymphocytic leukemia2023 | Publication without faculty affiliation
- Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study2016 | First Faculty of Medicine
- Severe secondary immune thrombocytopenia in a patient with chronic lymphocytic leukemia2022 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Dendritic cells in immunopathologyPublication without faculty affiliation
- New possibilities and perspectives of immunoglobulin therapy2016 | Second Faculty of Medicine
- Primární a sekundární imunodeficience, přehled a klasifikacePublication without faculty affiliation
- Efekt léčby ibrutinibem u relapsu CLL po alogenní transplantaci krvetvorných buněk2017 | First Faculty of Medicine
- Acalabrutinib2021 | Third Faculty of Medicine
- Small Molecules in the Treatment of Chronic Lymphocytic Leukemia in 2015 and in the Near Future2015 | First Faculty of Medicine
- Modern approach to the treatment of chronic lymphocytic leukemia2023 | Faculty of Medicine in Hradec Králové
- The terapeutic Options for ""Slow- go"" Patients with Chronic Lymphocytic Leukemia2015 | Faculty of Medicine in Hradec Králové